Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (236)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
11
2024
508
1.090
 Why?
Germ-Line Mutation
9
2013
61
1.070
 Why?
Hamartoma Syndrome, Multiple
8
2012
15
1.060
 Why?
PTEN Phosphohydrolase
13
2015
53
1.040
 Why?
Barrett Esophagus
2
2019
30
1.010
 Why?
Esophageal Neoplasms
2
2019
104
0.930
 Why?
Adenocarcinoma
3
2019
402
0.830
 Why?
Haplotypes
3
2020
84
0.770
 Why?
Homozygote
3
2019
57
0.660
 Why?
Polymorphism, Single Nucleotide
9
2021
484
0.660
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
154
0.630
 Why?
Proto-Oncogene Proteins c-akt
4
2012
155
0.590
 Why?
Databases, Factual
1
2020
660
0.560
 Why?
Alleles
6
2021
253
0.460
 Why?
Lung Neoplasms
3
2020
601
0.450
 Why?
Phosphatidylinositol 3-Kinases
2
2012
139
0.420
 Why?
Genotype
6
2021
542
0.400
 Why?
Scavenger Receptors, Class A
1
2011
39
0.370
 Why?
Extracellular Matrix Proteins
1
2011
69
0.370
 Why?
Genetic Variation
3
2021
215
0.300
 Why?
Transcription Factors
1
2011
563
0.290
 Why?
Breast Neoplasms
7
2017
1187
0.290
 Why?
Humans
37
2024
50201
0.280
 Why?
Thyroid Neoplasms
4
2012
113
0.280
 Why?
Heart Defects, Congenital
2
2024
590
0.270
 Why?
Case-Control Studies
4
2024
1145
0.260
 Why?
Genes, Wilms Tumor
1
2005
1
0.250
 Why?
Population
1
2005
8
0.250
 Why?
Gene Frequency
3
2020
96
0.250
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
13
0.240
 Why?
Genome
2
2019
66
0.240
 Why?
Lamin Type A
1
2024
6
0.230
 Why?
Capacity Building
1
2024
18
0.220
 Why?
DNA Methylation
3
2024
546
0.220
 Why?
Adult
16
2024
13486
0.220
 Why?
Middle Aged
16
2021
12356
0.220
 Why?
Linkage Disequilibrium
2
2020
37
0.210
 Why?
Female
21
2024
26829
0.210
 Why?
Smoke-Free Policy
1
2022
9
0.210
 Why?
Tobacco Smoke Pollution
1
2022
48
0.200
 Why?
Inheritance Patterns
1
2021
22
0.190
 Why?
Phenotype
7
2021
732
0.180
 Why?
Models, Genetic
5
2013
174
0.180
 Why?
Risk Factors
5
2019
3644
0.180
 Why?
Male
15
2024
25572
0.180
 Why?
Succinate Dehydrogenase
2
2011
22
0.170
 Why?
Stilbenes
2
2010
54
0.170
 Why?
Aged
11
2020
9505
0.170
 Why?
Fires
1
2020
14
0.170
 Why?
Agriculture
1
2020
18
0.170
 Why?
Tobacco Products
1
2021
125
0.170
 Why?
Social Media
1
2021
98
0.170
 Why?
Cluster Analysis
4
2013
233
0.160
 Why?
Aged, 80 and over
5
2020
3158
0.160
 Why?
Exome
1
2019
46
0.160
 Why?
Genomics
1
2020
284
0.150
 Why?
Cell Proliferation
3
2010
987
0.150
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
132
0.150
 Why?
Prostatic Neoplasms
2
2012
393
0.140
 Why?
Gene Expression Regulation, Neoplastic
3
2010
824
0.140
 Why?
Prognosis
2
2020
1963
0.140
 Why?
Endometrial Neoplasms
2
2015
137
0.130
 Why?
Leprosy
1
2016
6
0.130
 Why?
Asthma
1
2020
282
0.130
 Why?
Hypertension
1
2021
541
0.130
 Why?
Emergency Service, Hospital
1
2020
482
0.130
 Why?
Microsatellite Repeats
2
2012
37
0.120
 Why?
Regression Analysis
2
2017
395
0.120
 Why?
Aromatase
1
2015
8
0.120
 Why?
Tuberculosis
1
2016
148
0.120
 Why?
Arkansas
4
2024
1988
0.120
 Why?
Genetic Linkage
2
2011
26
0.110
 Why?
Young Adult
7
2021
4052
0.110
 Why?
Sirolimus
2
2010
62
0.110
 Why?
Adolescent
8
2021
6459
0.110
 Why?
Genome-Wide Association Study
2
2012
163
0.110
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
1
0.110
 Why?
Smad4 Protein
1
2013
5
0.110
 Why?
Genetic Testing
2
2010
119
0.110
 Why?
Cohort Studies
3
2012
1414
0.110
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
17
0.110
 Why?
Colonic Polyps
1
2013
36
0.100
 Why?
Receptors, Cell Surface
1
2013
120
0.100
 Why?
Mitochondrial Diseases
1
2012
42
0.100
 Why?
Codon, Nonsense
1
2012
26
0.100
 Why?
Flavin-Adenine Dinucleotide
1
2011
4
0.100
 Why?
NAD
1
2011
42
0.100
 Why?
Antigens, CD
1
2013
216
0.100
 Why?
Genes, p53
1
2011
51
0.100
 Why?
DNA, Neoplasm
1
2012
146
0.090
 Why?
Siblings
1
2011
33
0.090
 Why?
Gene Expression Profiling
3
2012
1029
0.090
 Why?
Mutation, Missense
1
2012
104
0.090
 Why?
Taxoids
1
2011
37
0.090
 Why?
Adenoma
1
2012
111
0.090
 Why?
Risk
1
2012
315
0.090
 Why?
Software
1
2013
273
0.090
 Why?
Intestinal Polyps
1
2010
7
0.090
 Why?
Colorectal Neoplasms
2
2012
255
0.090
 Why?
Receptors, Androgen
1
2010
46
0.090
 Why?
Cephalometry
1
2010
19
0.090
 Why?
Tumor Microenvironment
1
2012
222
0.090
 Why?
Head
1
2010
70
0.080
 Why?
Gene Dosage
1
2009
78
0.080
 Why?
Carcinoma, Transitional Cell
1
2010
52
0.080
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
139
0.080
 Why?
Patient Selection
1
2010
254
0.080
 Why?
Cell Communication
1
2009
69
0.080
 Why?
Drug Resistance, Neoplasm
1
2011
315
0.080
 Why?
Age Factors
1
2012
1096
0.080
 Why?
Urinary Bladder Neoplasms
1
2010
158
0.080
 Why?
Immunohistochemistry
1
2011
973
0.080
 Why?
Smoking
1
2012
506
0.080
 Why?
Prevalence
2
2021
960
0.070
 Why?
Chromosome Mapping
2
2021
158
0.070
 Why?
Prospective Studies
4
2017
2396
0.070
 Why?
Mass Screening
1
2010
348
0.070
 Why?
Rural Population
2
2022
551
0.070
 Why?
Cell Line, Tumor
4
2011
1390
0.070
 Why?
Physical Chromosome Mapping
1
2005
7
0.070
 Why?
Multiple Myeloma
1
2020
2934
0.070
 Why?
Antineoplastic Agents
2
2011
1176
0.060
 Why?
Frasier Syndrome
1
2005
1
0.060
 Why?
Denys-Drash Syndrome
1
2005
3
0.060
 Why?
Exons
1
2005
95
0.060
 Why?
Child
5
2020
6862
0.060
 Why?
CpG Islands
1
2024
106
0.060
 Why?
Models, Theoretical
1
2005
174
0.060
 Why?
Gene Expression Regulation
1
2008
964
0.050
 Why?
Mutation
2
2010
1288
0.050
 Why?
Biopsy
1
2005
592
0.050
 Why?
Polyproteins
1
2022
2
0.050
 Why?
Child, Preschool
3
2020
3896
0.050
 Why?
Risk Assessment
2
2021
1255
0.050
 Why?
Phosphoproteins
1
2022
111
0.050
 Why?
RNA, Viral
1
2022
124
0.050
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
5
0.050
 Why?
United States Food and Drug Administration
1
2021
91
0.050
 Why?
Membrane Glycoproteins
1
2022
244
0.050
 Why?
Azacitidine
1
2020
34
0.050
 Why?
Nutrition Surveys
1
2021
103
0.050
 Why?
Loss of Heterozygosity
2
2012
77
0.050
 Why?
United States
2
2021
4898
0.040
 Why?
Stromal Cells
2
2012
72
0.040
 Why?
Nicotine
1
2021
182
0.040
 Why?
TOR Serine-Threonine Kinases
2
2010
77
0.040
 Why?
Self Report
1
2021
202
0.040
 Why?
Pedigree
2
2010
125
0.040
 Why?
Seasons
1
2020
81
0.040
 Why?
Neoplasms
1
2009
1233
0.040
 Why?
Air Pollution
1
2020
45
0.040
 Why?
Odds Ratio
1
2021
548
0.040
 Why?
Signal Transduction
3
2010
1612
0.040
 Why?
Phosphorylation
2
2010
525
0.040
 Why?
Gene Expression
2
2012
612
0.040
 Why?
Sensitivity and Specificity
2
2012
871
0.040
 Why?
Predictive Value of Tests
2
2012
921
0.040
 Why?
Treatment Outcome
2
2020
5203
0.040
 Why?
Dexamethasone
1
2020
434
0.040
 Why?
Infant
2
2020
3584
0.040
 Why?
Angiopoietin-2
1
2017
15
0.040
 Why?
Dose-Response Relationship, Drug
2
2010
1356
0.040
 Why?
Angiopoietin-1
1
2017
16
0.040
 Why?
Receptor, TIE-2
1
2017
16
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
34
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
46
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
87
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
183
0.030
 Why?
Cross-Sectional Studies
1
2021
1580
0.030
 Why?
Neovascularization, Pathologic
1
2017
153
0.030
 Why?
Neoadjuvant Therapy
1
2017
119
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
49
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1000
0.030
 Why?
Pilot Projects
1
2016
703
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
 Why?
Databases, Genetic
1
2013
87
0.030
 Why?
Genome, Human
1
2013
110
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Penetrance
1
2012
6
0.020
 Why?
Neoplasm Grading
1
2012
123
0.020
 Why?
Genetic Association Studies
1
2012
115
0.020
 Why?
Vincristine
1
2011
85
0.020
 Why?
Anthracyclines
1
2011
29
0.020
 Why?
Inhibitory Concentration 50
1
2010
71
0.020
 Why?
Paclitaxel
1
2011
83
0.020
 Why?
Formazans
1
2010
4
0.020
 Why?
Tetrazolium Salts
1
2010
15
0.020
 Why?
Immunoblotting
1
2010
116
0.020
 Why?
Androgen Antagonists
1
2010
11
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
81
0.020
 Why?
Drug Synergism
1
2010
152
0.020
 Why?
HEK293 Cells
1
2011
217
0.020
 Why?
Michigan
1
2010
17
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
17
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
153
0.020
 Why?
Point Mutation
1
2010
65
0.020
 Why?
Epithelial Cells
1
2012
210
0.020
 Why?
Neoplasm Transplantation
1
2010
84
0.020
 Why?
Kidney Neoplasms
1
2012
173
0.020
 Why?
Androgens
1
2010
67
0.020
 Why?
Heredity
1
2009
2
0.020
 Why?
Transplantation, Heterologous
1
2010
75
0.020
 Why?
BRCA2 Protein
1
2009
16
0.020
 Why?
Adenosine Triphosphate
1
2011
230
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
76
0.020
 Why?
BRCA1 Protein
1
2009
30
0.020
 Why?
Comparative Genomic Hybridization
1
2009
46
0.020
 Why?
Polymerase Chain Reaction
1
2011
456
0.020
 Why?
Proteins
1
2012
348
0.020
 Why?
Mice, Nude
1
2010
252
0.020
 Why?
Chi-Square Distribution
1
2010
280
0.020
 Why?
Cell Cycle
1
2010
226
0.020
 Why?
Algorithms
1
2013
615
0.020
 Why?
Protein Binding
1
2011
655
0.020
 Why?
Gene Deletion
1
2010
267
0.020
 Why?
Diagnosis, Differential
1
2012
1041
0.020
 Why?
Cell Survival
1
2010
590
0.020
 Why?
Incidence
1
2012
1000
0.020
 Why?
Neoplasm Invasiveness
1
2009
269
0.020
 Why?
Neoplastic Stem Cells
1
2009
100
0.020
 Why?
Promoter Regions, Genetic
1
2010
466
0.020
 Why?
Membrane Proteins
1
2010
347
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
181
0.020
 Why?
Neoplasm Staging
1
2011
749
0.020
 Why?
Microscopy, Confocal
1
2008
83
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
409
0.020
 Why?
Cell Differentiation
1
2011
648
0.020
 Why?
Chromosome Aberrations
1
2009
295
0.020
 Why?
Survival Rate
1
2010
906
0.020
 Why?
Registries
1
2010
527
0.020
 Why?
Chromosomes, Human
1
2005
41
0.020
 Why?
Time Factors
1
2010
2909
0.010
 Why?
Reproducibility of Results
1
2005
1195
0.010
 Why?
Mice
1
2010
5673
0.010
 Why?
Animals
1
2010
13141
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (236) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department